Browse Category

Investment Analysis News 23 January 2026

PepsiCo stock slips even as Coca-Cola rises; traders eye Feb. 3 earnings

PepsiCo stock slips even as Coca-Cola rises; traders eye Feb. 3 earnings

PepsiCo shares slipped 0.2% to $144.05 Friday, trailing gains in Coca-Cola and Mondelez, as the consumer staples sector edged higher. The stock remains about 10% below its 52-week high after a 1.6% drop Thursday. Investors are watching next week’s Federal Reserve decision and PepsiCo’s Feb. 3 earnings report for direction.
AbbVie stock rises as India rejects Venetoclax patent bid; ABBV traders eye Feb. 4 earnings

AbbVie stock rises as India rejects Venetoclax patent bid; ABBV traders eye Feb. 4 earnings

AbbVie shares rose 0.6% to $219.33 Friday after India’s patent office rejected the company’s bid to patent blood-cancer drug venetoclax, raising prospects for generics. The Health Care Select Sector SPDR Fund fell 0.6%. Investors are watching for AbbVie’s Feb. 4 earnings after recent guidance cuts and U.S. pricing deals.
Charles Schwab stock slips after earnings pop as analysts lift targets

Charles Schwab stock slips after earnings pop as analysts lift targets

Charles Schwab shares fell 1.3% to $102.71 Friday afternoon after reporting a 19% jump in fourth-quarter net revenue to $6.34 billion and record client assets of $11.90 trillion. Barclays and Jefferies raised their price targets this week following the results. Schwab’s net income reached $2.46 billion, or $1.33 per share. Trading volume topped 5 million shares.
Intuitive Surgical stock price dips as 2026 da Vinci outlook cools after Q4 beat (ISRG)

Intuitive Surgical stock price dips as 2026 da Vinci outlook cools after Q4 beat (ISRG)

Intuitive Surgical shares fell 0.2% to $524.65 after the company forecast slower da Vinci procedure growth of 13–15% for 2026, down from 18% in 2025. Fourth-quarter revenue rose 19% to $2.87 billion, with adjusted profit topping estimates. Management cited tariff risks and rising competition as headwinds. The company installed 532 da Vinci systems in Q4, bringing its total to 11,106.
BigBear.ai (BBAI) stock flat after SEC filing delays share vote again; CargoSeer deal in focus

BigBear.ai (BBAI) stock flat after SEC filing delays share vote again; CargoSeer deal in focus

BigBear.ai delayed its shareholder vote on doubling authorized common stock to Feb. 18, with voting open through Feb. 17, according to an SEC filing. Shares slipped 0.1% to $5.93 Friday after the announcement. The company also disclosed it acquired specific CargoSeer cargo inspection technologies; terms were not released. Pomerantz Law Firm said it is investigating claims on behalf of BigBear.ai investors.
GE Vernova stock price slips after Power unit CEO exit; earnings next week in focus

GE Vernova stock price slips after Power unit CEO exit; earnings next week in focus

GE Vernova shares fell 0.1% to $660.79 by midday Friday after hitting a session low of $649.65, extending losses from earlier in the week. Mavi Zingoni stepped down as Power segment CEO on Jan. 21, with Eric Gray taking over. Investors await the company’s Jan. 28 earnings report for updates on order flow and margins. The stock closed Wednesday at $667.89, about 8.6% below its December high.
Robinhood stock rises on MIAXdx deal closure — what traders watch next

Robinhood stock rises on MIAXdx deal closure — what traders watch next

Robinhood shares rose about 2% Friday after a joint venture with Susquehanna bought a majority stake in MIAXdx, a CFTC-regulated derivatives exchange. Miami International Holdings retains 10%. Investors await Robinhood’s Feb. 10 earnings for details on costs and rollout. Coinbase and Charles Schwab shares fell, while Bitcoin edged higher.
Johnson & Johnson stock today: Why JNJ can’t break out as talc risk shadows upbeat 2026 outlook

Johnson & Johnson stock today: Why JNJ can’t break out as talc risk shadows upbeat 2026 outlook

Johnson & Johnson shares traded nearly flat at $218.59 by late Friday morning as Wall Street upgrades met renewed worries over federal talc lawsuits. A special master recommended allowing plaintiffs’ experts to testify that J&J talc products can cause ovarian cancer, affecting over 67,500 cases. The company reported Q4 sales up 9.1% to $24.6 billion and projected 2026 sales of up to $101 billion.
Intel stock sinks in premarket after weak outlook; AI data-center supply crunch bites

Intel stock sinks in premarket after weak outlook; AI data-center supply crunch bites

Intel shares fell about 12% in premarket trading Friday after the company forecast weaker-than-expected Q1 revenue and earnings. The drop could erase $31 billion in market value. Executives cited tight supply for server CPUs amid surging AI data-center demand. Analysts criticized management for underestimating the server cycle.
Atul Q3 results: profit jumps 40% but labour-code costs bite; shares end higher

Atul Q3 results: profit jumps 40% but labour-code costs bite; shares end higher

Atul Ltd shares rose 1.03% to 5,833.25 rupees after reporting a 40% year-on-year profit jump to 163.54 crore rupees for the December quarter, with revenue up 11% to 1,573.62 crore. Operating expenses climbed 2.9% from the previous quarter, and employee benefit costs surged due to a 41.35 crore rupee provision for new labour codes. Indian stocks closed lower, with the Nifty 50 down 0.95%.
CSL share price rises on ASX as U.S. vaccine policy shifts rattle the sector

CSL share price rises on ASX as U.S. vaccine policy shifts rattle the sector

CSL Ltd shares closed 0.7% higher at A$179.62 Friday, extending Thursday’s gains, with 1.01 million shares traded. The stock’s rise comes as U.S. vaccine policy changes under Health Secretary Robert F. Kennedy Jr. weigh on sentiment for CSL’s Seqirus unit. CSL delayed a Seqirus spinoff and cut its 2026 growth forecast in October, citing falling U.S. flu vaccination rates. Half-year results are due Feb. 11.
Capital One stock ends higher after Brex deal; 10% rate-cap talk clouds COF outlook

Capital One stock ends higher after Brex deal; 10% rate-cap talk clouds COF outlook

Capital One shares rose 1.8% to $235.07 after the company announced a $5.15 billion deal to acquire corporate card fintech Brex and reported fourth-quarter earnings. Net interest income jumped 54% to $12.47 billion, while adjusted earnings missed Wall Street estimates. Investors weighed the news alongside a White House proposal for a 10% cap on credit-card interest rates.
1 32 33 34 35 36 282

Stock Market Today

Meta stock faces an AI split: ad gains vs a $135 billion bill

Meta stock faces an AI split: ad gains vs a $135 billion bill

7 February 2026
Meta shares dropped 1.3% to $661.46 on Friday after the company projected 2026 capital spending of up to $135 billion, raising investor concerns over cash flow. Meta reported Q4 revenue of $59.89 billion, up 24% year-over-year, with ad impressions rising 18%. Analysts remain divided on whether AI-driven ad gains can offset the steep spending ramp.
IAG share price jumps toward a 52-week peak — what to watch before London reopens

IAG share price jumps toward a 52-week peak — what to watch before London reopens

7 February 2026
IAG shares rose 4.33% to 438.50 pence Friday, near their 52-week high, ahead of full-year results due later this month. The company reported 162,073,135 treasury shares and total voting rights of 4,565,128,012. Brent crude fell 2.2% Thursday to $67.93 a barrel. South Europe Ground Services logged 712,340 operations in 2025 and seeks approval to operate in Portugal.
Go toTop